Bayer Aktiengesellschaft (OTCMKTS:BAYRY) Reaches New 1-Year High – What’s Next?

Shares of Bayer Aktiengesellschaft (OTCMKTS:BAYRY) reached a new 52-week high on Tuesday. The stock traded as high as $15.98 and last traded at $15.9760, with a volume of 417,025 shares trading hands. The stock had previously closed at $15.91.

Bayer Aktiengesellschaft Trading Up 0.4%

The firm has a market cap of $62.76 billion, a PE ratio of -34.72, a P/E/G ratio of 1.90 and a beta of 0.57. The company’s fifty day moving average price is $13.54 and its two-hundred day moving average price is $12.62. The company has a quick ratio of 0.67, a current ratio of 1.04 and a debt-to-equity ratio of 1.05.

Bayer Aktiengesellschaft (OTCMKTS:BAYRY) last released its earnings results on Tuesday, November 3rd. The company reported $0.11 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.13 by ($0.02). The company had revenue of $11.25 billion during the quarter, compared to analysts’ expectations of $11.21 billion. Bayer Aktiengesellschaft had a negative net margin of 3.28% and a positive return on equity of 16.34%. As a group, sell-side analysts forecast that Bayer Aktiengesellschaft will post 1.29 earnings per share for the current fiscal year.

About Bayer Aktiengesellschaft

Bayer Aktiengesellschaft is a German life sciences company headquartered in Leverkusen. Founded in 1863, it develops products and services in pharmaceuticals, consumer health and agriculture. Its Pharmaceuticals business offers prescription medicines, including treatments in areas such as cardiovascular disease, oncology, women’s health and eye care. Consumer Health sells nonprescription medicines and self-care products, with brands including Claritin, Aleve and One A Day. Through its Crop Science business, Bayer provides seeds, crop protection products and agricultural solutions for farmers.